MY MEDICAL^blog

Posted: «InternationalMedical Journal », № 1, 2002 Treatment is most severe disease is alwaysactual problem medicine ⇒⇒⇒

about small business in the eyes of TV RTR "Traffic. Tragedy called coaxil »After drinking the blood of small businesses paid an ambulance and medical transport,TV reporters are now pressed pharmacy. All newly puts ⇒⇒⇒

How to 5 common dasgs. Then they asked: "Howyou take medication? ". All participants spokein English, had no problems with hearing and vision. 46.3% of participants could notcorrectly understood ⇒⇒⇒

Alexander Chekalin: "If we do not suppress these facts, they can nullify theAll efforts of the State in this sphere ". Russia at present, according to international experts, is the secondafter China's position on the propagation ⇒⇒⇒

Cancer Research Institute. Gertsen Doctormedical sciences professor Igor Reshetov. The other day at the institute, we operated on 42-year old man with malignanttumors in half his face. Noting in his nova ⇒⇒⇒

Indian children received vitamin A as part of disease preventionof view. According to Reuters, after it has been vaccinated, hundreds of children inaged to 6 years began to come into the hospital with complaints ⇒⇒⇒

⇒⇒⇒

Modern marketing techniques can not onlyimprove the economic performance of any pharmaceuticalorganization, but also form one of the sustainable competitive advantage -purchasing commitment ⇒⇒⇒

Schiffer) prompted its mechanism of action. He is, first, reduces the formation ofDopamine, one of the most important substance in the brain. Second, it increasesactivity of GABA, a substance that exerts an inhibitory effect on dopamine. However, ⇒⇒⇒

Plenary sessions were devoted to analysis of achievements and potential prospectsClinical application Roncoleukin ®; approach to immunotherapy inwhole. In separate reports were submitted: - application Roncoleukin ® in pulmonary tuberculosis, severehormone-dependent bronchial asthma, chronic viral hepatitis Crecurrent pseudotuberculosis in children with chronic chlamydial infection,recurrent genital herpes, myocardial infarction; - Experimental data on the effectiveness of Roncoleukin ® for high-riskbacterial and viral infections; - Principles for the Roncoleukin ® in disseminated forms of malignantneoplasms. The materials of the symposium can be found atwww.biotech.spb.com/main.php?menu=bookslist=findid=245 We will be happy to discuss immunotherapy Roncoleukin ® Onlinewww.biotech.spb.com/main.php?menu=foasm      ⇒⇒⇒